Two Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders

Andrew R. Branagan(Massachusetts General Hospital), Madhav V. Dhodapkar(Yale Cancer Center), Eamon Duffy(Auckland City Hospital), Lin Zhang(Yale Cancer Center), Rakesh Verma(Harvard University), Fangyong Li(Yale University), Connor Foster(Yale Cancer Center)
Cited by 6


Related Papers